Your email has been successfully added to our mailing list.

×
0.00019319938176194 0.00038639876352388 0.00154559505409579 -0.00154559505409593 -0.00309119010819172 0.000309119010819131 0.00019319938176194 0.00349304482225653
Stock impact report

Anokion Announces the Early Completion of Enrollment in the ACeD-it Phase 2 and the SynCeD Phase 2a Trials of KAN-101 for the Treatment of Celiac Disease [Yahoo! Finance]

Pfizer, Inc. (PFE) 
Last pfizer, inc. earnings: 4/28 06:45 am Check Earnings Report
Company Research Source: Yahoo! Finance
Celiac Disease is a serious autoimmune disease that currently has no approved therapeutic treatments CAMBRIDGE, Mass. & LAUSANNE, Switzerland, December 19, 2024 BUSINESS WIRE Anokion SA , a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced the early completion of patient dosing in the Phase 2 ACeD-it and Phase 2a SynCeD trials of KAN-101, a potential disease-modifying treatment for celiac disease. Topline data from both the Phase 2 ACeD-it and Phase 2a SynCeD clinical trials are expected in the first half of 2025. KAN-101 is a novel immune tolerance therapy, which encompasses an established gluten antigen delivered to the liver and im Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Created with Highstock 5.0.1230sec1m5m10m30m60m90m120m-0.50%-0.25%0.00%0.25%0.50%
Opt-in for PFE alerts
Opt-in for
PFE alerts

from News Quantified
Opt-in for
PFE alerts

from News Quantified